Perindopril: all 38 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationNCT07547878Phase 4
- Timely Recovery After Subclinical Heart FailureRecruitingNCT06341101Phase 4
- Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting ConditionsRecruitingNCT06213610Phase 1
- ACES - ACE Inhibitors Combined With Exercise for Seniors With HypertensionCompletedNCT03295734Phase 2Results posted
- Phase II Study of Perindopril and Regorafenib in mCRCCompletedNCT02651415Phase 2Results posted
- Chronic Subdural Hematoma - Reduction of Recurrence by Treatment With Angiotensin Converting Enzyme InhibitorsTerminatedNCT00915928Not applicableResults posted
- Treatment Optimisation for Blood Pressure With Single-Pill Combinations in IndiaCompletedNCT05683301Phase 4
- Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and DyslipidemiaTerminatedNCT04591808Phase 3
- Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast CancerCompletedNCT04588935Phase 2
- One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart DiseaseStatus unknownNCT04148820Phase 4
- Moxonidine + Perindopril in Hypertensive Patients With Metabolic SyndromeStatus unknownNCT04023565Phase 4
- Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.CompletedNCT03921736Phase 4
- Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 DiabetesCompletedNCT03747978Phase 4
- Effect of Morning Versus Evening Perindopril on Blood Pressure Control in People With Type 2 DiabetesCompletedNCT03393715Phase 4
- Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT)Status unknownNCT03249285Phase 3
- Fixed Combination for Lipid and Blood Pressure ControlWithdrawnNCT03047538Phase 4
- Fixed vs Free Dose of ACEi/CCB Combination TherapyCompletedNCT02995954Phase 4
- Influence of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese SubjectsTerminatedNCT02777489Phase 2
- Comparison of Three Combination Therapies in Lowering Blood Pressure in Black AfricansCompletedNCT02742467Phase 4
- Perindopril vs Ramipril for Persistence in MAU Reduction StudyCompletedNCT02729441Phase 3
- Once-daily Fixed Combination of Three Antihypertensive DrugsStatus unknownNCT02710539Phase 4
- DOXAZOSIN FOR PTSDCompletedNCT02308202Phase 1
- Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver DiseaseStatus unknownNCT02213224Phase 4
- Pilot Study of Perindopril in Childhood Cancer SurvivorsWithdrawnNCT01948232Phase 2
- Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke PatientsStatus unknownNCT01819441Phase 4
- Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting ConditionCompletedNCT01682577Not applicable
- PREclinical Mutation CARriers From Families With DIlated Cardiomyopathy and ACE InhibitorsTerminatedNCT01583114Phase 3
- Comparison of Medical Therapies in Marfan Syndrome.CompletedNCT01295047Phase 4
- Influence of Aliskiren on ProteinuriaCompletedNCT01219413Phase 4
- An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine DependenceCompletedNCT01062451Phase 1
- Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fed ConditionsCompletedNCT01013155Not applicable
- Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fasted ConditionsCompletedNCT01012687Not applicable
- Angiotensin Converting Enzyme Inhibitors in Marfan SyndromeCompletedNCT00485368Phase 3
- Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential HypertensionCompletedNCT00461903Phase 3
- Evaluation of Myocardial Improvement in Patients Supported by Ventricular Assist Device Under Optimal Pharmacological TherapyTerminatedNCT00402376Phase 4
- S90652 in Paediatric HypertensionCompletedNCT00202592Phase 2
- S90652 in Paediatric HypertensionCompletedNCT00202553Phase 2
- IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering DrugsCompletedNCT00128518Phase 4